Defiance Leveraged Long +Income HIMS ETF(HIMY.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Defiance Leveraged Long +Income HIMS ETF
HIMY.US
News
View More

Hims uses new Super Bowl ad to tackle healthcare affordability

Hims & Hers is launching a new Super Bowl ad addressing healthcare affordability, shifting focus from Big Pharma to the privatized U.S. healthcare system. The ad, narrated by rapper Common, highlights the disparity in healthcare access between the wealthy and the general public, emphasizing that the rich have better healthcare options. Hims & Hers aims to democratize access to personalized care, challenging the status quo and advocating for a system that benefits everyone, not just the affluent. The company anticipates controversy similar to last year's ad, as it confronts uncomfortable truths about healthcare inequality.

Fiercepharma·
US
VHT
+0.42%
US
HIMS
-1.68%
US
HIMZ
-3.92%
Fiercepharma·
US
VHT
+0.42%
US
HIMS
-1.68%
US
HIMZ
-3.92%

Hims & Hers attacks the rich in its Super Bowl ad — including a Jeff Bezos lookalike

Hims & Hers attacks the rich in its Super Bowl ad — including a Jeff Bezos lookalike

businessinsider·
US
XHS
+0.77%
US
XLV
+0.42%
US
HIMZ
-3.92%
businessinsider·
US
XHS
+0.77%
US
XLV
+0.42%
US
HIMZ
-3.92%

10:51 ET Cold Spring Harbor Laboratory Appoints Jack Abraham and Terri Keogh to Board of Trustees

The Cold Spring Harbor Laboratory (CSHL) has appointed Jack Abraham, founder and CEO of Atomic, and Terri Keogh, President and CEO of Castro Properties, to its Board of Trustees. Abraham brings extensive entrepreneurial experience, having co-founded several successful companies, including Hims & Hers. Keogh has a strong background in commercial real estate and has been involved with CSHL since 2019. Both are expected to contribute significantly to the institution's mission in science and medicine.

prnewswire·
US
VHT
+0.42%
US
XHS
+0.77%
US
IXJ
+0.43%
prnewswire·
US
VHT
+0.42%
US
XHS
+0.77%
US
IXJ
+0.43%

Looking At Hims & Hers Health's Recent Unusual Options Activity

Investors are taking a bearish stance on Hims & Hers Health (NYSE:HIMS), with 14 unusual options trades detected. The sentiment is split, with 35% bullish and 50% bearish. Significant trades include 2 puts totaling $53,536 and 12 calls totaling $530,252. The price range targeted by large investors is between $30.0 and $100.0. Currently, HIMS is trading at $30.17, down 2.94%, with a consensus target price of $33.0 from market experts. The next earnings report is due in 27 days.

benzinga_article·
US
HIMY
0.00%
US
VHT
+0.42%
US
IXJ
+0.43%
benzinga_article·
US
HIMY
0.00%
US
VHT
+0.42%
US
IXJ
+0.43%

The 2026 Healthcare Reset: Subscription Economics Meets MRI-Grade AI Precision

The medical imaging market is shifting towards economic accountability, with AI cardiac platforms expected to reach a $2.57 trillion valuation by 2026. Companies like VentriPoint Diagnostics are leading this change by developing subscription models that enhance cardiac imaging accuracy while reducing costs. VentriPoint's recent funding increase to $1 million will support commercialization and regulatory efforts. The company is also partnering with Summit Sciences to create ROI models for hospitals, emphasizing economic value alongside clinical capabilities. Additionally, LifeMD and Hims & Hers are expanding their telehealth services in the weight management sector.

Baystreet·
US
HIMS
-1.68%
US
IHF
-0.36%
US
XHS
+0.77%
Baystreet·
US
HIMS
-1.68%
US
IHF
-0.36%
US
XHS
+0.77%
© 2026 Longbridge｜Disclaimer